Safety and immunogenicity of HBAI20 Hepatitis B vaccine in healthy naive and nonresponding adults

O. M. Koc, P. H. M. Savelkoul, I. H. M. van Loo, A. Peeters, A. M. L. Oude Lashof*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1048-1056
Number of pages9
JournalJournal of Viral Hepatitis
Volume25
Issue number9
DOIs
Publication statusPublished - Sep 2018

Keywords

  • adjuvant
  • HBAI20
  • Hepatitis B
  • immunogenicity
  • nonresponder
  • safety
  • vaccine
  • CONTROLLED CLINICAL-TRIAL
  • CHRONIC UREMIC PATIENTS
  • LOW-DOSE INTERLEUKIN-2
  • T-CELL-ACTIVATION
  • RECOMBINANT INTERLEUKIN-2
  • DENDRITIC CELLS
  • SURFACE-ANTIGEN
  • INFLUSOME-VAC
  • DIFFERENTIATION
  • EFFICACY

Cite this

@article{b0979167f6aa49ce8fbf044a7561b8e7,
title = "Safety and immunogenicity of HBAI20 Hepatitis B vaccine in healthy naive and nonresponding adults",
keywords = "adjuvant, HBAI20, Hepatitis B, immunogenicity, nonresponder, safety, vaccine, CONTROLLED CLINICAL-TRIAL, CHRONIC UREMIC PATIENTS, LOW-DOSE INTERLEUKIN-2, T-CELL-ACTIVATION, RECOMBINANT INTERLEUKIN-2, DENDRITIC CELLS, SURFACE-ANTIGEN, INFLUSOME-VAC, DIFFERENTIATION, EFFICACY",
author = "Koc, {O. M.} and Savelkoul, {P. H. M.} and {van Loo}, {I. H. M.} and A. Peeters and Lashof, {A. M. L. Oude}",
year = "2018",
month = "9",
doi = "10.1111/jvh.12909",
language = "English",
volume = "25",
pages = "1048--1056",
journal = "Journal of Viral Hepatitis",
issn = "1352-0504",
publisher = "Wiley",
number = "9",

}

Safety and immunogenicity of HBAI20 Hepatitis B vaccine in healthy naive and nonresponding adults. / Koc, O. M.; Savelkoul, P. H. M.; van Loo, I. H. M.; Peeters, A.; Lashof, A. M. L. Oude.

In: Journal of Viral Hepatitis, Vol. 25, No. 9, 09.2018, p. 1048-1056.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Safety and immunogenicity of HBAI20 Hepatitis B vaccine in healthy naive and nonresponding adults

AU - Koc, O. M.

AU - Savelkoul, P. H. M.

AU - van Loo, I. H. M.

AU - Peeters, A.

AU - Lashof, A. M. L. Oude

PY - 2018/9

Y1 - 2018/9

KW - adjuvant

KW - HBAI20

KW - Hepatitis B

KW - immunogenicity

KW - nonresponder

KW - safety

KW - vaccine

KW - CONTROLLED CLINICAL-TRIAL

KW - CHRONIC UREMIC PATIENTS

KW - LOW-DOSE INTERLEUKIN-2

KW - T-CELL-ACTIVATION

KW - RECOMBINANT INTERLEUKIN-2

KW - DENDRITIC CELLS

KW - SURFACE-ANTIGEN

KW - INFLUSOME-VAC

KW - DIFFERENTIATION

KW - EFFICACY

U2 - 10.1111/jvh.12909

DO - 10.1111/jvh.12909

M3 - Article

VL - 25

SP - 1048

EP - 1056

JO - Journal of Viral Hepatitis

JF - Journal of Viral Hepatitis

SN - 1352-0504

IS - 9

ER -